Exploration of N-(2-aminoethyl)piperidine-4-carboxamide as a potential scaffold for development of VEGFR-2, ERK-2 and Abl-1 multikinase inhibitor-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Exploration of N-(2-aminoethyl)piperidine-4-carboxamide as a potential scaffold for development of VEGFR-2, ERK-2 and Abl-1 multikinase inhibitor

Published:2013-09 Issue:18 Volume:21 Page:5694-5706
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Jin Feng,Gao Dan,Wu Qin,Liu Feng,Chen Yuzong,Tan Chunyan,Jiang Yuyang

Funder

Ministry of Science and Technology of China

National Natural Science Foundation of China

Science Industry Trade and Information Technology Commission of Shenzhen Municipality

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference57 articles.

1. Selection of new chemical entities with decreased potential for adverse drug reactions

2. Novel inhibitors in development for hepatocellular carcinoma

3. The present and the future landscape of treatment of advanced hepatocellular carcinoma

4. New Pharmacological Developments in the Treatment of Hepatocellular Cancer

5. Beyond sorafenib: novel targeted therapies for advanced hepatocellular carcinoma

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis, molecular docking and in vitro anticancer activities of 1-(4-(benzamido)phenyl)-3-arylurea derivatives;RSC Advances;2024

2. Discovery of Novel Quinazoline-2-Aminothiazole Hybrids Containing a 4-Piperidinylamide Linker as Potential Fungicides against the Phytopathogenic Fungus Rhizoctonia solani;Journal of Agricultural and Food Chemistry;2022-08-12

3. Development of small molecule extracellular signal-regulated kinases (ERKs) inhibitors for cancer therapy;Acta Pharmaceutica Sinica B;2022-05

4. Hyperactivation of MAPK Induces Tamoxifen Resistance in SPRED2-Deficient ERα-Positive Breast Cancer;Cancers;2022-02-14

5. In Silico Screening of Available Drugs Targeting Non-Small Cell Lung Cancer Targets: A Drug Repurposing Approach;Pharmaceutics;2021-12-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3